Late-onset Systemic Lupus Erythematosus
Rheumatology International,
Journal Year:
2025,
Volume and Issue:
45(1)
Published: Jan. 15, 2025
Language: Английский
Delayed onset lupus nephritis in the course of systemic lupus erythematosus: Relation to disease activity and therapeutic response
The Egyptian Rheumatologist,
Journal Year:
2025,
Volume and Issue:
47(2), P. 65 - 69
Published: Jan. 17, 2025
Language: Английский
Does the Time to the Onset of Lupus Nephritis Impact Renal Disease Presentation and Outcomes?
Seminars in Arthritis and Rheumatism,
Journal Year:
2025,
Volume and Issue:
unknown, P. 152724 - 152724
Published: April 1, 2025
Language: Английский
Malignancy in systemic lupus erythematosus: relation to disease characteristics in 92 patients – a single center retrospective study
Rheumatology International,
Journal Year:
2024,
Volume and Issue:
44(9), P. 1701 - 1713
Published: June 8, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
chronic
autoimmune
disease
with
variable
clinical
manifestation,
potentially
leading
to
death.
Importantly,
patients
SLE
have
an
increased
risk
of
neoplastic
disorders.
Thus,
this
study
aimed
comprehensively
evaluate
the
and
laboratory
characteristics
or
without
malignancy.
Language: Английский
Comparison of Clinical and Laboratory Characteristics in Lupus Nephritis vs. Non-Lupus Nephritis Patients—A Comprehensive Retrospective Analysis Based on 921 Patients
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(15), P. 4486 - 4486
Published: July 31, 2024
Background:
Lupus
nephritis
(LN)
is
an
inflammation
of
the
kidneys
that
related
to
systemic
lupus
erythematosus
(SLE).
This
study
aimed
evaluate
differences
in
clinical
and
laboratory
characteristics
between
LN
non-LN
SLE
patients.
Methods:
We
conducted
a
retrospective
analysis
medical
records
collected
from
patients
treated
at
University
Hospital
Kraków,
Poland,
2012
2022.
All
met
2019
European
League
Against
Rheumatism
American
College
Rheumatology
(EULAR/ACR)
criteria
for
SLE.
Results:
Among
921
patients,
was
documented
331
(35.94%).
were
younger
diagnosis
(29
vs.
37
years;
p
<
0.001)
had
male
proportion
2.09
times
higher
than
group
(16.62%
7.97%;
0.001).
They
more
often
diagnosed
with
serositis
hematological
or
neurological
involvement
(p
0.001
all).
Hypertension
hypercholesterolemia
occurred
frequently
these
both).
exhibited
frequency
anti-dsDNA,
anti-histone,
anti-nucleosome
antibodies
Conversely,
1.24-fold
(95%
CI:
1.03–1.50;
=
0.021)
increase
odds
ratio
having
positive
anti-cardiolipin
IgM
antibody
results.
immunosuppressants.
The
risk
factors
experiencing
least
three
flares
included
female
sex,
age
onset
SLE,
occurring
later
onset,
presence
anti-dsDNA
antibodies,
certain
manifestations
such
as
myalgia,
arthritis,
proteinuria
>
3.5
g/day,
pathological
urinary
casts
urine
sediment.
Conclusions:
differ
diagnosis,
treatment
modalities,
autoantibody
profile
have
frequent,
severe
However,
we
still
need
prospective
studies
understand
diversity
its
progression
Language: Английский
Clinical and laboratory profiles of systemic lupus erythematosus patients in a new rheumatology clinic in southwestern Nigeria
Reumatologia/Rheumatology,
Journal Year:
2024,
Volume and Issue:
62(2), P. 83 - 93
Published: May 10, 2024
Introduction
The
aims
were
to
study
the
sociodemographic
characteristics
of
patients
presenting
clinic
and
clinical
serological
pattern
systemic
lupus
erythematosus
(SLE)
in
a
new
rheumatology
predominantly
Yoruba
population.
Material
methods
This
was
retrospective,
cross-sectional
conducted
over
7
years
(January
2017
–
December
2023).
Patients
who
satisfied
1997
American
College
Rheumatology
(ACR)
and/or
2012
Systemic
Lupus
International
Collaborating
Clinics
(SLICC)
classification
criteria
enrolled
using
their
medical
records.
with
overlap
syndromes
other
inflammatory
or
noninflammatory
rheumatic
diseases
excluded
from
study.
Their
sociodemographic,
clinical,
laboratory,
treatment
data
retrieved
records
analysed
IBM
SPSS
version
23.0
software.
Results
A
total
65
diagnosed
SLE
frequency
15.8%.
mean
age
±SD
at
presentation
33.85
±11.01
female
male
ratio
9.8
:
1.
median
(IQR)
duration
symptoms
7.0
months
(3–24).
common
presentations
included
synovitis
(86.2%),
acute
cutaneous
rash
(53.8%),
oral
ulcers
(52.3%),
nonscarring
alopecia
(50.8%),
serositis
(47.7%).
Proteinuria
seen
37.7%
predominant
renal
histopathological
feature
Class
IV.
Antinuclear
antibody
100%
positive
50.94%
having
titre
1
5,120
above.
Anti-
double-stranded
deoxyribonucleic
acid
anti-Smith
antibodies
each
had
50%
prevalence.
Dyslipidaemia
found
76.7%
patients.
Conclusions
study’s
findings
are
largely
consistent
similar
studies
done
Africa.
Further
prospective
multi-centred
needed
further
determine
epidemiological
disease
Nigeria
multi-ethnic
Language: Английский
The diagnostic and predictive potential of lncRNA CASC2 targeting miR-155 in systemic lupus erythematosus patients with nephritis complication
Nesrine A Mohamed,
No information about this author
Abeer l. Abd El-Fattah,
No information about this author
Olfat Shaker
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Dec. 17, 2024
Abstract
Lupus
nephritis
(LN)
is
a
serious
problem
that
results
from
systemic
lupus
erythematosus
(SLE)
complications.
Recent
studies
have
highlighted
non-coding
RNA
(ncRNA)
dysregulation
notable
feature
in
patients
with
SLE.
As
result,
this
research
was
designed
to
investigate
lncRNA
CASC2
and
miR-155
levels
as
non-invasive
diagnostic
biomarkers
SLE
patients,
including
those
without
nephritis,
their
effectiveness
assessing
disease
severity
predicting
LN.
Our
study
included
60
who
were
subclassified
into
(30
non-LN
30
LN
groups),
along
control
subjects.
Quantification
of
serum
samples
the
Egyptian
population
carried
out
real-time
polymerase
chain
reaction
(RT-PCR).
The
activity
index
(SLEDAI)
for
evaluated,
analysis
receiver
operating
characteristic
(ROC)
curve
implemented.
Increased
observed
compared
healthy
controls,
even
higher
group
versus
patients’
group.
Conversely,
noted
be
down-regulated
relative
its
lower
elevated
expression
reduced
both
correlated
disease.
current
illustrated
could
act
valuable
among
well
abilities
detect
progression.
Language: Английский
Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study
Lupus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 12, 2024
To
summarize
the
causes
of
death
and
clinical
characteristics
systemic
lupus
erythematosus
(SLE)
hospitalized
patients
in
last
20
years
to
improve
SLE
survival
rates
by
detecting
critical
early.
Language: Английский
Comprehensive Insights into Neuropsychiatric Systemic Lupus Erythematosus
Quality in Sport,
Journal Year:
2024,
Volume and Issue:
18, P. 53423 - 53423
Published: Aug. 12, 2024
Introduction:
Systemic
lupus
erythematosus
(SLE)
is
a
chronic
autoimmune
disease,
often
affecting
women
of
childbearing
age,
with
periods
exacerbations
and
remissions.
SLE
can
impact
multiple
organs,
causing
range
clinical
symptoms.
Neuropsychiatric
systemic
(NPSLE)
includes
symptoms
like
headaches,
seizures,
anxiety
disorders,
cognitive
dysfunctions,
psychosis,
neuropathies.
Its
diagnosis
challenging,
treatment
complex.
Purpose:
This
study
aims
to
explain
the
pathophysiology
NPSLE,
describe
diagnostic
methods,
summarize
current
methods
based
on
recent
research.
Methods:
Databases
such
as
PubMed,
Medline,
ResearchGate
were
used.
State
knowledge:
Early
accurate
crucial
for
optimal
patient
management.
The
2019
EULAR/ACR
classification
criteria
have
improved
precision
weighted
scoring
system
diverse
disease
manifestations.
Therapy
neuropsychiatric
focuses
symptom
control
causal
treatment,
considering
anti-inflammatory
action
or
counteracting
ischemic
incidents.
It
involves
immunosuppressive
agents
antiplatelet
anticoagulant
substances.
Non-pharmacological
interventions
lifestyle
modifications
are
also
important.
dynamic
reflect
ongoing
advancements
in
understanding
SLE,
emphasizing
continuous
research
collaboration.
Conclusions:
NPSLE
requires
excluding
other
causes
symptoms,
infections,
endocrine
drug
reactions.
Diagnostic
vary
including
lumbar
puncture,
CSF
analysis,
EEG,
function
assessment,
MRI.
therapy
individualized
severity
burden.
Language: Английский
Exposure to Gold Induces Autoantibodies against Nuclear Antigens in A.TL Mice
Sara Puente-Marín,
No information about this author
Said Havarinasab
No information about this author
Biology,
Journal Year:
2024,
Volume and Issue:
13(10), P. 812 - 812
Published: Oct. 11, 2024
To
demonstrate
causation
or/and
assess
pathogenic
mechanisms
of
environment-induced
autoimmunity,
various
animal
models
that
mimic
the
characteristics
human
autoimmune
diseases
need
to
be
developed.
Experimental
studies
in
mice
reveal
genetic
factors
contribute
diseases.
Here,
immune
response
two
mouse
strains
congenic
for
non-H-2
genes,
A.TL
(H-2
Language: Английский